본문으로 건너뛰기
← 뒤로

Coaxial-Nanocables Constructed Flexible Aptasensor for Ultrafast Blood-Drop Detection of Prostate Cancer.

1/5 보강
Small (Weinheim an der Bergstrasse, Germany) 📖 저널 OA 17.2% 2024: 1/2 OA 2025: 4/33 OA 2026: 6/29 OA 2024~2026 2025 Vol.21(31) p. e2504714
Retraction 확인
출처

Yuan X, Liu X, Zhu M, Zhang W, Liu T, Xie Y

📝 환자 설명용 한 줄

Prostate cancer (PCa) is the second most common cancer for male health with ultrahigh recurrence rates to cause high mortality.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Yuan X, Liu X, et al. (2025). Coaxial-Nanocables Constructed Flexible Aptasensor for Ultrafast Blood-Drop Detection of Prostate Cancer.. Small (Weinheim an der Bergstrasse, Germany), 21(31), e2504714. https://doi.org/10.1002/smll.202504714
MLA Yuan X, et al.. "Coaxial-Nanocables Constructed Flexible Aptasensor for Ultrafast Blood-Drop Detection of Prostate Cancer.." Small (Weinheim an der Bergstrasse, Germany), vol. 21, no. 31, 2025, pp. e2504714.
PMID 40465367 ↗

Abstract

Prostate cancer (PCa) is the second most common cancer for male health with ultrahigh recurrence rates to cause high mortality. However, clinical imaging and biopsy techniques suffer the bulky testing equipment and high cost, and blood assay requires blood pretreatment before analysis to significantly restrict home-in self-examination and postoperative follow-up of PCa. Herein, a blood-drop 4-min-test technique is designed to precisely screen PCa by a high-ordered coaxial-nanocables-based aptasensor. The electrospinning potential is employed as the driving force to regulate the distribution of mixed reduced graphene oxide and polyacrylonitrile from disorder to highly order to large-scale weave coaxial nanocables-based films. This architecture has contributed abundant active DNA bonding sites and served as 3D network electron transmission channels to dramatically amplify detection signals with short response time. Moreover, a target-induced chain release strategy is implemented to precisely capture the PCa biomarker. Furthermore, a household PCa analyzer is developed to achieve ultrafast, precise, and nonhospital assays of clinical patients within 4 min which is 30 times faster than the state-of-the-art commercial instruments. This high-performance analyzer has great potential for early screening and prognostic evaluation of PCa to benefit real-time tests for both in-hospital and nonhospital patients.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반